In a letter to the FDA, members of Congress cite confusion over healthcare providers’ deployment of clinical decision support software exempt from medical device regulations and say clarity is needed from its Center for Devices and Radiological Health. Analytics, AI, Clinical and business intelligence, Regulation, Emerging Technologies, Machine learning, Data and Information, Public Policy, Technology News from healthcareitnews.com
In a letter to the FDA, members of Congress cite confusion over healthcare providers’ deployment of clinical decision support software exempt from medical device regulations and say clarity is needed from its Center for Devices and Radiological Health.
